Stay updated on Comparison of Treatments for TFE/tRCC Clinical Trial

Sign up to get notified when there's something new on the Comparison of Treatments for TFE/tRCC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Comparison of Treatments for TFE/tRCC Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The study record describes a phase 2 trial of axitinib and nivolumab for TFE/translocation renal cell carcinoma, including treatment arms, eligibility criteria, outcome measures, and study locations. It also shows the study is active but no longer recruiting and includes posted results and study documents.
    Difference
    100%
    Check dated 2026-11-07T12:51:45.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    The site footer’s revision label changed from v3.7.2 to v3.8.0 while the page continued to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-31T13:49:28.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    A sitewide banner announces NIH website updates and says that federal agencies are using “Super Intelligence” in place of “Artificial Intelligence” during a transition.
    Difference
    1%
    Check dated 2026-10-24T17:54:49.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    The revision identifier in the page footer changed from v3.7.1 to v3.7.2 while the study page continued to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-17T20:08:08.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    The site footer revision identifier changes from v3.7.0 to v3.7.1; the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-10T20:30:03.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    The page now renders a 403 Forbidden error instead of the study content, displaying minimal navigation and an error message. This indicates restricted access to the study information.
    Difference
    17%
    Check dated 2026-09-19T20:22:14.000Z thumbnail image

Stay in the know with updates to Comparison of Treatments for TFE/tRCC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Comparison of Treatments for TFE/tRCC Clinical Trial page.